Bioorganic and Medicinal Chemistry Letters p. 907 - 911 (2010)
Update date:2022-09-26
Topics:
Lowe III, John A.
DeNinno, Shari L.
Drozda, Susan E.
Schmidt, Christopher J.
Ward, Karen M.
David Tingley III
Sanner, Mark
Tunucci, Don
Valentine, James
We describe a novel series of inhibitors of the type 1 glycine transporter (GlyT1) as an approach to relieving the glutamatergic deficit that is thought to underlie schizophrenia. Synthesis and SAR follow-up of a series of octahydro-cyclopenta[c]pyrrole derivatives afforded potent in vitro inhibition of GlyT1 as well as in vivo activity in elevating CSF glycine. We also found that a 3-O(c-pentyl), 4-F substituent may serve as a surrogate for the widely used 3-trifluoromethoxy group, suggesting its application as an isostere for future medicinal chemistry studies.
View MoreChangsha Yonta Industry Co., Ltd.
Contact:+ 86-731-8535 2228
Address:Rm.1717, North Bldg., No.368, East 2nd Ring Road(2nd Section)
Jiangsu Fengshan Group Co., Ltd.
Contact:86-25-86558671
Address:1903,Central International Mansion 105-6 North Zhongshan Road, Nanjing, China
Chengdu NoVi Biotechnology Co., Ltd.(expird)
Contact:13551243286/028-81458053
Address:NO.168-1-224 JULONG ROAD WUHOU DISTRICT, CHENGDU CITY,SICHUAN PROVINCE
Chengdu Chengnuo New-Tech Co., Ltd
Contact:0086-028-85749078
Address:4 Jiuyang road,Jiulong industrial port,Chengdu, China
Shanghai Korey Pharm Co.,Ltd.(expird)
Contact:021-61840961 021-61840962
Address:No.157,Zhuguang Rd, Qingpu, Shanghai, China
Doi:10.1016/S0040-4020(01)86080-4
(1988)Doi:10.1016/S0277-5387(00)86440-2
(1989)Doi:10.3762/bjoc.15.48
(2019)Doi:10.1002/jhet.292
(2010)Doi:10.1021/ja201561z
(2011)Doi:10.1016/j.tet.2017.12.015
(2018)